WHO Supports Shift in US Approach to Preventing Chronic Diseases

The WHO has endorsed the US's renewed focus on prevention to combat chronic diseases, emphasizing the need to address root causes and promote healthier habits for improved public health outcomes.
The World Health Organization (WHO) has expressed support for the United States' renewed emphasis on prevention efforts to combat chronic illnesses. Recently, US Health Secretary Robert F. Kennedy Jr. has advocated for increased focus on preventative strategies, encouraging the adoption of healthier habits among the population. This stance has garnered some criticism from the WHO, which has noted Kennedy's vaccine-skeptical views and his Make America Healthy Again (MAHA) movement. Despite this, WHO Director-General Tedros Adhanom Ghebreyesus emphasized his support for the emphasis on disease prevention, acknowledging the significant health challenges faced by the US.
Tedros highlighted that the US is among the top countries affected by non-communicable diseases such as obesity, cardiovascular conditions, and cancers, despite the country’s substantial healthcare expenditure. He pointed out that much of the high healthcare costs are due to a focus on treatment rather than prevention. Addressing root causes through early intervention could prove more cost-effective and beneficial.
A prominent event during the upcoming UN General Assembly in New York will focus on improving strategies against non-communicable diseases, which include heart disease, cancer, and diabetes—leading causes of death worldwide. Tedros indicated a desire to collaborate with the US on prioritizing preventive health initiatives, expecting US leadership in this global health effort.
This renewed focus on prevention aligns with the global recognition that tackling the root causes of chronic diseases can substantially reduce their burden, improve population health, and lower healthcare costs. The WHO’s backing signals a global commitment to shifting healthcare priorities from treatment to prevention, aiming for better health outcomes worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Promising Results in First Human Trial of Targeted Therapy for Relapsed Small Cell Lung Cancer
A Phase I study showcases promising safety and efficacy data of SHR-4849, a targeted antibody-drug conjugate, in relapsed small cell lung cancer patients, paving the way for further clinical development.
Innovative Online Toolkit Supports Better Dental Health for Autistic Children
A new online toolkit developed by the University of Leeds provides tailored guidance to help parents of autistic children improve dental health and reduce decay, promoting lifelong oral hygiene practices.
Impact of Plant-Based Molecules on the Effectiveness of Cancer Treatments
Emerging research reveals that small molecules in plant-based foods processed by gut bacteria can reduce the effectiveness of cancer drugs by accelerating their clearance, highlighting the role of diet and microbiome in treatment outcomes.
Rising Gonorrhea Cases Highlight Challenges of Antibiotic Resistance
Gonorrhea cases are rising worldwide, fueled by increasing antibiotic resistance, making effective treatment more challenging. Researchers are working on new drugs to combat resistant strains and prevent severe health complications.



